Back to Results
First PageMeta Content
Medicine / Bacillus Calmette-Guérin / Mycobacterium / Pyrazinamide / Antibiotic resistance / Latent tuberculosis / Rifampicin / M. bovis / Middlebrook 7H9 Broth / Bacteria / Tuberculosis / Microbiology


Antimicrobial Treatment Improves Mycobacterial Survival in Nonpermissive Growth Conditions Obolbek Turapov,a Simon J. Waddell,b Bernard Burke,a Sarah Glenn,a Asel A. Sarybaeva,a Griselda Tudo,c* Gilles Labesse,d,e
Add to Reading List

Open Document

File Size: 885,36 KB

Share Result on Facebook

City

Barnsley / Leicester / Ciencia / Barcelona / Sommer / Boshoff / /

Company

Becton / Dickinson and Company / Amersham Biosciences / LG / ABC / Wellcome Trust / William Freeman Ltd. / Ford / HP / Creative Commons / Belanger AE / /

Country

United Kingdom / United States / Spain / /

Currency

pence / /

/

Event

Product Issues / /

Facility

Colorado State University / Aberystwyth University / St. George’s University of London / University of Sussex / Institute of Biological / University of Leicester / Hospital Clínic / /

IndustryTerm

treatment of infectious diseases / translation machinery / cellular export machinery / energy metabolism / plasmid systems / immobilized-metal affinity high-performance column / toxic by-products / therapies for persistent infectious diseases / energy-consuming processes / /

MedicalCondition

M. tuberculosis H37Rv / mouse infection / JE / Mycobacterium tuberculosis H37Rv / Macrophage infection / Active starvation / starvation / Several infectious diseases / J. Cancer / untreated M. tuberculosis / persistent predator Mycobacterium tuberculosis / infection / chronic infection / infectious disease / DF / M. tuberculosis DNA / TB / M. tuberculosis / strain / successful M. tuberculosis / infections / Mycobacterium tuberculosis / persistent M. tuberculosis / latent tuberculosis / infectious diseases / vivo macrophage infection / persistent infectious diseases / tuberculosis / /

MedicalTreatment

adjunctive therapy / resuscitation / antibiotics / chemotherapy / drug therapy / /

NaturalFeature

Gallegos MT / /

Organization

University of Leicester / Centre for Core Biotechnology Services / Schlumberger Foundation / University of Sussex / Institute of Biological / Environmental and Rural Sciences / Aberystwyth University / University of London / London / Sussex Medical School / FDA / European Union / Department of Infection / Immunity and Inflammation / Centre de Biochimie Structurale / Barcelona Centre for International Health Research / National Institute of Health / Division of Clinical Sciences / Colorado State University / Centre for Infection and Immunity / Home Office / Research Ethics Committee / /

Person

Roland Brosch / Denise Waldron / Nat / Alexa Fluor / Gilles Labesse / Brian Robertson / Peter W. Andrew / Galina V. Mukamolovaa / Adam Witney / Griselda Tudo / Michael Young / Martin Cohen-Gonsaud / Tanya Parish / Danielle I. Young / Nino Iakobachvili / Natalie Garton / Galina V. Mukamolova / Bokum Iakobachvili / /

Position

Butcher / Brynildsen MP / Collins JJ / Philip D. Butcher / /

Product

reserpine / dextrose / pyrazinamide / metronidazole / DV / Nokia E75 Smartphone / isoniazid / rifampin / isoflurane / Sterile water / GS / INH / aminophylline / dimethyl sulfoxide / efflux / /

ProvinceOrState

Sussex / /

PublishedMedium

Antimicrobial Agents and Chemotherapy / Infection and Immunity / /

Technology

drug discovery / 1986 protocols / DNA Chip / Chemotherapy / recombination / flash / published protocol / Biotechnology / transcriptomics / DNA binding / artificial intelligence / http / determined using a published protocol / /

URL

http /

SocialTag